GLIONOVA
Glionova AB, a development stage biopharmaceutical company, is engaged in the development of therapies for difficult-to-treat cancers. The company develops GLN-1001, an orally bioavailable small molecule that induces selective cell death in glioblastoma cells without causing harm to normal brain tissue.
GLIONOVA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.glionova.com
Total Employee:
1+
Status:
Active
Contact:
+46 70 540 6519
Total Funding:
5.7 M USD
Technology used in webpage:
OpenResty Baidu Analytics DNS.COM
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Employees Featured
Founder
Investors List
Novo Holdings
Novo Holdings investment in Series A - Glionova
HealthCap
HealthCap investment in Series A - Glionova
Industrifonden
Industrifonden investment in Series A - Glionova
More informations about "Glionova"
Home | elionova.com
We are a dynamic team of experienced professionals who are passionate about using technology to improve people's health and well-being.. Our team is composed of highly skilled and …See details»
Glionova - Crunchbase Company Profile & Funding
Glionova AB, a development stage biopharmaceutical company, is engaged in the development of therapies for difficult-to-treat cancers. The company develops GLN-1001, an orally …See details»
Team | elionova.com
Hans-Peter Meyer (Dr. rer. nat) Biotechnologist, Chairman of the Board and Partner Expertinova AG, Board Member CHoNova AG, Board Member Elionova AG, Head scientific advisory board …See details»
Glionova Therapeutics - VentureRadar
"Glionova AB is a privately-held development stage biopharmaceutical company based in Stockholm, Sweden. We are dedicated to the development of innovative therapies for difficult …See details»
Glionova - Funding, Financials, Valuation & Investors - Crunchbase
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.See details»
Glionova - Contacts, Employees, Board Members, Advisors & Alumni
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.See details»
Evinova
Evinova offers a suite of globally-scaled digital health solutions, empowering sites, sponsors and Contract Research Organizations (CROs) to optimize the entire clinical development lifecycleSee details»
Company | elionova.com
ELIONOVA, domiciled in Fribourg, Switzerland, was founded in September 2020 as spin-off from EXPERTINOVA. The company is owned by EXPERTINOVA and the company management. …See details»
Elionova Company Profile 2024: Valuation, Funding & Investors
Elionova General Information Description. Developer of innovative diagnostic products headquartered in Friborg, Switzerland. The company focuses on providing rapid and highly …See details»
Elionova AG – Swiss Biotech
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework …See details»
Glionova - Crunchbase
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.See details»
News | elionova.com
Dec 7, 2020 The WAVLD is an organization of veterinarians who are dedicated to the promotion of quality veterinary laboratory diagnostic medicine throug... Jun 27, 2023. ... Elionova AG, …See details»
Glionova (company) - Nordic 9
Glionova (company). Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer. The company is engaged in the development of …See details»
Elionova AG - Crunchbase Company Profile & Funding
Organization. Elionova AG . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Elionova AG is a medical and diagnostic laboratories. ... Elionova AG is to …See details»
Founding Elionova AG
Elionova AG was founded on Sept. 25th, 2020 and is managed and build-up by a highly experienced team consisting of six to eight Senior Partners of Expertinova. In this way, we …See details»
Products | elionova.com
Products. Our products are (1) the reading instrument and (2) diagnostic assays for human and animal health.. Assays consist of 8-well one-way biosensor test devices made from standard …See details»
Elionova AG - startup.ch
Elionova AG: we provide scientists with a new diagnostic platformSee details»
Elionova Is Revolutioninzing the Rapid Testing Market
ELIONOVA is now working on EVA tests to test platelet donors and recipients to ensure the success of a platelet transfusion, or to detect the level of protective antibodies in the body of a …See details»
Technology | elionova.com
Evanescence Technology (EVA) ELIONOVA's Real-Time immunoassay technology is based ton fluorescence waveguide laser evanescent illumination. Key features of the technology are: …See details»
Privacy Policy | elionova.com
Contact addresses Responsibility for processing personal data: Elionova AG Passage du Cardinal 13b 1700 Friborg Switzerland Data protection officer: r We have the following data protection …See details»